Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 2.5x - 2.7x | 2.6x |
| Historical Pb Multiple | 0.0x - 2.9x | 2.6x |
| Fair Value | ﷼42.27 - ﷼46.72 | ﷼44.50 |
| Upside | 8.9% - 20.4% | 14.7% |
| Benchmarks | - | Full Ticker |
| Professional Medical Expertise Company | 957,400.0% | SASE:9574 |
| Future Care Trading Co. | 954,400.0% | SASE:9544 |
| Ayyan Investment Company | 214,000.0% | SASE:2140 |
| Arabian International Healthcare Holding Company | 953,000.0% | SASE:9530 |
| Mouwasat Medical Services Company | 400,200.0% | SASE:4002 |
| Scientific and Medical Equipment House Company | 401,400.0% | SASE:4014 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 9574 | 9544 | 2140 | 9530 | 4002 | 4014 | |||
| SASE:9574 | SASE:9544 | SASE:2140 | SASE:9530 | SASE:4002 | SASE:4014 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | 8.9% | -14.2% | ||
| 3Y CAGR | 38.8% | -19.3% | NM- | -26.5% | 3.8% | -24.9% | ||
| Latest Twelve Months | 20.8% | 106.9% | -113.7% | 68.9% | 1.3% | -24.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 11.3% | 30.6% | -32.2% | 8.2% | 26.5% | 6.2% | ||
| Prior Fiscal Year | 10.8% | 15.0% | -13.2% | 3.2% | 24.3% | 6.3% | ||
| Latest Fiscal Year | 9.9% | 26.8% | -34.3% | 4.7% | 22.4% | 3.7% | ||
| Latest Twelve Months | 9.9% | 24.4% | -46.8% | 3.9% | 23.0% | 3.6% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 30.7% | 23.5% | -4.5% | 18.3% | 22.6% | 9.8% | ||
| Prior Fiscal Year | 33.7% | 9.1% | -0.4% | 6.6% | 21.2% | 10.0% | ||
| Latest Twelve Months | 32.4% | 17.9% | -0.8% | 11.3% | 18.6% | 6.2% | ||
| Next Fiscal Year | 39.1% | 27.0% | #NUM! | 24.8% | 22.7% | 11.2% | ||
| Two Fiscal Years Forward | 36.5% | 25.1% | -0.9% | 25.5% | 19.7% | 12.7% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 1.2x | 29.9x | 110.7x | 0.8x | 5.1x | 1.3x | ||
| Price / LTM EPS | 12.3x | 122.3x | -236.6x | 20.6x | 22.0x | 36.6x | ||
| Price / Book | 3.4x | 20.1x | 1.5x | 2.2x | 3.9x | 2.3x | ||
| Price / Fwd Book | 2.5x | 16.3x | 2.3x | 1.6x | 3.6x | 2.2x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 1.5x | 3.4x | 20.1x | |||||
| Historical P/B Ratio | 0.0x | 2.6x | 2.9x | |||||
| Selected P/B Multiple | 2.5x | 2.6x | 2.7x | |||||
| (x) Book Value | 511 | 511 | 511 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 9574 | 9544 | 2140 | 9530 | 4002 | 4014 | |
| Value of Common Equity | 324 | 1,580 | 1,423 | 614 | 14,900 | 1,164 | |
| (/) Shares Outstanding | 3.5 | 500.0 | 100.6 | 19.8 | 200.0 | 30.0 | |
| Implied Stock Price | 92.60 | 3.16 | 14.14 | 31.05 | 74.50 | 38.80 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 92.60 | 3.16 | 14.14 | 31.05 | 74.50 | 38.80 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |